NOVEMBER 20239It is vital to develop a common goal in the design phase and move from concept to completion through collaborationDHT deployment which are Integrated, Interoperable and Interactive. DHTs should be a two-way interactive communication between the patient and healthcare provider. It should be user friendly and easy to access. It is vital to know where along the patient journey is the DHT interaction playing its role. This can include symptom tracking using patient reported outcomes, patient-initiated request for appointment and review, reminders for healthcare episodes as well as therapeutics and support. Digital therapeutics such as the use of interactive problem-solving, video education and interventions as well as virtual reality can be deployed remotely when there is a need based on the assessment made. Patients retain autonomy and choice in the use of the interactive DHTs. Clinician recommendation and support can increase the participation in the interaction with DHTs. Thirdly, DHTs must be preventive. This is a paradigm shift and holistic re-examination of the use of DHTs. This is a move away from the reactive to the proactive health management. DHTs such as wearables and continuous measurement of data that is private and secure can help inform choices and decisions around health care topics that promote wellbeing. This gives insights into patients' lived experience while having a strong emphasis on data security and transparency. This will help address the full spectrum of the patient needs throughout the end-to-end pathway and go beyond just the clinic interaction.DHTs hold the promise of transforming healthcare with its unprecedented adoption from COVID-19. It can improve safety and quality of care. This must be balanced with the Ux, democratisation of information and equity. With the promise of future benefits from DHTs, the investment should not be purely monetary but also into the cultural transformation where patients are involved from the early stages with co-production of DHTs. It is vital to develop a common goal in the design phase and move from concept to completion through collaboration. This will ensure increased uptake and adoption to achieve the primary goal of improved patient care and outcomes.
< Page 8 | Page 10 >